Particle.news
Download on the App Store

PIKfyve Loss Breaks Photoreceptor Recycling and Raises Drug Safety Concerns

The study shows PIKfyve is essential for photoreceptor and RPE lysosomal clearance and prompts scrutiny of systemic PIKfyve inhibitors in clinical trials.

Overview

  • The peer-reviewed mouse study by University of Oklahoma researchers was published in Cell Death & Disease and reported across outlets on July 29–30, 2026.
  • Researchers found photoreceptors maintain an internal lysosomal recycling system that depends on the lipid kinase PIKfyve rather than relying solely on the retinal pigment epithelium for all waste clearance.
  • Genetic deletion of PIKfyve in mice caused buildup of damaged proteins in photoreceptors, vacuoles and lysosomal marker changes, loss of outer nuclear layer thickness, and reduced rod and cone function.
  • PIKfyve loss in RPE cells produced lipid and debris accumulation that mimics age-related macular degeneration, and partial PIKfyve reduction sped degeneration in P23H rhodopsin mutant mice used to model inherited retinitis pigmentosa.
  • The work points to PIKfyve as a possible therapeutic target to protect vision but also warns that systemic PIKfyve inhibitors such as Apilimod, now in clinical development, should be evaluated for retinal toxicity before human use.